ReviewThe oncologist2019

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges.

Xiufeng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.